Andrx considers Altocor name change
Executive Summary
Andrx is considering changing the name of the extended-release statin Altocor (lovastatin) to Altoprev. FDA approved the name Altoprev in an Aug. 20 1letter. Andrx submitted the sNDA with the proposed name change Dec. 5, 2002...